Massachusetts-based Moderna will likely be the first to manufacture a bird flu vaccine, backed by hundreds of millions in government funding. The biopharmaceutical giant is developing the vaccine as a ...
Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...
The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...
Moderna Inc (NASDAQ:MRNA) stock is surging today, up 8.7% at $37.02 at last glance, after the vaccine maker was awarded $590 ...
“In Asia, people buy live birds at markets where they are plucked. The plucking has been shown to aerosolize virus from the ...
To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about 72 ...